Current Landscape and the Potential Role of Hypoxia-Inducible Factors and Selenium in Clear Cell Renal Cell Carcinoma Treatment.

Int J Mol Sci · 2018 · PMC6321165 · PMID 30513765

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a strong trendno p-value reported

IFN-α as a monotherapy has fallen out of favor, as a phase III multinational trial between sunitinib and IFN-α demonstrated a strong trend toward a median overall survival advantage of sunitinib over IFN-α [ 33 ].

also in 5,725 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.